Add To Watchlist
Share URL
About The Company
Description
BriaCell Therapeutics Corp.
Read More
Overview
Value
2
Growth
39
Health
43
Management
49
Analyst Opinion
60
Total
39
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Poor earnings and cashflow growth
Latest News

BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th
GlobeNewsWire | 15:15 Wed 28 Sept 2022
Read More →

Why Is BriaCell (BCTX) Stock Moving Today?
InvestorPlace | 16:34 Wed 13 Apr 2022
Read More →

Why BriaCell Therapeutics Stock Is Surging Today
Benzinga | 15:28 Wed 13 Apr 2022
Read More →

Big Trade Sends Briacell Therapeutics Stock Higher
Schaeffers Research | 14:41 Thu 16 Dec 2021
Read More →
Market Peers
BCTX
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-88.85%
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Neutral
Share Buybacks
-145.32%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
2
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 0.8 USD ✘
Current Price: 7 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-13.04%
PE/Earnings Growth
N/A
Price/Book
10.57x
Growth
Growth Score
39
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 24.63% is higher than the market average (14.48%)
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -2.75% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
N/A
Earnings Growth
24.63%
Cashflow Growth
-2.75%
Health
Health Score
43
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
N/Ax
Current Assets/Liabilities
45.00x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
N/Ax
Management
Management Score
49
Average Buybacks/Dilution
-145.32%
Recent Buybacks/Dilution
0.15%
5 Year Price Volitility
29.40%
Return On Assets
N/A
Return On Capital Employed
N/A
Return On Equity
N/A
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
60
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
BriaCell Therapeutics Corp.
Currency
USD
Beta
1.377443
Vol Avg
247250
Ceo
Cik
0001610820
Cusip
Exchange
NASDAQ Capital Market
Full Time Employees
5
Industry
Biotechnology
Sector
Healthcare
Ipo Date
2010-10-28
Address
Bellevue Centre
City
West Vancouver
State
BC
Country
CA
Zip
V7T 2X1
Phone
All financial data provided by FMP